Agilent Technologies Authorizes $2 Billion Share Repurchase Program

Agilent Technologies, Inc. (NYSE: A) announced on Monday that its board of directors has approved a new share repurchase program authorizing the purchase of up to $2 billion of the company’s common stock.

The new program, which begins March 1, will replace Agilent’s existing stock repurchase program. "Agilent is committed to balanced capital deployment that drives growth and helps deliver strong returns for shareholders," said Bob McMahon, Agilent’s chief financial officer. "This share repurchase program is a key element of that strategy."

The number of shares to be repurchased and the timing of any repurchases will depend on factors such as stock price, economic and market conditions. The stock repurchase program may be suspended or discontinued at any time.

Agilent operates in the life sciences, diagnostics, and applied chemical markets. The company reported revenue of $6.85 billion in fiscal year 2022 and employs 18,000 people worldwide.